NCT07602907 2026-05-22Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion TrialZhejiang Cancer HospitalPhase 2 Not yet recruiting44 enrolled